ÂÜÀòÂÒÂ×

Douglas Hervey is a partner at Cicero Group and is the firm’s healthcare and private equity lead. He has worked on over 200 healthcare private equity investment deals, within 80 unique healthcare sub-segments, for over 40 investment funds. Douglas has also assisted many leading Fortune 500 health systems, payers, technology, medical device, and pharmaceutical companies deliver patient and consumer value through payment and delivery reforms. His thought leadership has been featured in the Harvard Business Review and Health Affairs.

Douglas began his career practicing law in Washington, D.C., representing a number of large medical device, pharma, and health systems. During 2010 and 2011 he worked for innovation expert Harvard Business School Professor Clayton Christensen on value-based care and collaborated with several healthcare and technology startups. He has also worked as a director at The Beacon Group where he specialized in market entry strategy, competitive analysis, and the commercialization of new technologies. Douglas most recently worked as a senior director for Leavitt Partners. As a senior director, Douglas enabled healthcare entities to enhance their product and service offerings and make sound growth-oriented strategic and investment decisions.

Douglas earned his bachelor’s degree in international relations at Brigham Young University, after which he earned his juris doctorate from the University of Pittsburgh. Douglas also holds an MBA from Brigham Young University, where he was a Hawes Scholar.